The Drug Enforcement Administration (DEA) stated that the marijuana rescheduling appeal process remains “pending,” despite previous directives from President Donald Trump to expedite the reform. The DEA noted that “no briefing schedule has been set.”
A recent analysis coauthored by a former senior advisor at the DEA critiques current federal marijuana laws as “neither coherent nor evidence-based,” asserting that they cause significant harm. The analysis advocates for a shift towards a managed market access schedule for substances like cannabis and psilocybin, suggesting that capitalism controls could replace criminalization.
Legislative Movements and State-Level Actions
Representative Thomas Massie (R-KY) voiced support for allowing states to legalize cannabis independently of federal oversight, although he personally favors “medical margaritas” over recreational marijuana. In Pennsylvania, Governor Josh Shapiro (D) is urging lawmakers to legalize marijuana, emphasizing that it could generate revenue for investments in education, public safety, and the economy. “Stop with the excuses. Let’s get this done,” he stated.
Governor Mike Kehoe (R) of Missouri expressed the need to impose restrictions on intoxicating hemp-derived THC products, aligning with recent legislative actions sent to his office. Meanwhile, the Idaho House of Representatives has passed a resolution encouraging voters not to support a medical cannabis initiative for the upcoming November ballot, citing concerns about potential increases in crime and public safety issues.
In Ohio, a judge issued a temporary restraining order against new restrictions on hemp products, arguing that such policies shield the in-state marijuana industry from competition with out-of-state federally legal hemp products.
State Developments and Community Impact
The White House Office of National Drug Control Policy held an event recognizing law enforcement’s role in combatting drug trafficking. In legislative updates, the House bill aimed at designating psychedelic therapy centers of excellence has garnered support from a new cosponsor, bringing the total to 25.
Discussing medical cannabis in Oklahoma, Republican gubernatorial candidates shared their concerns during a recent debate. In Florida, the agriculture commissioner reported ongoing success in court against challenges from the hemp industry regarding laws designed to protect children from high-potency THC products. The Massachusetts Senate Ways and Means Committee has proposed a budget seeking $1 million for public education about marijuana risks.
The Illinois Medical Cannabis Advisory Board voted to recommend adding sickle cell disease as a qualifying condition for medical marijuana. In Vermont, regulators have released guidance on cannabis rules ahead of 4/20, while California regulators updated the transition process for provisional cannabis licenses to annual status. Montana regulators also provided various updates in a recent newsletter.
In local policy discussions, the Minneapolis City Council is contemplating a proposal to decriminalize drug paraphernalia.
Research Insights and Market Developments
A study in Germany found no increase in cannabis consumption following its legalization. Another study indicated that the inclusion of cannabis seeds can enhance lipid metabolism without negatively affecting growth in poultry.
In business news, Vireo Growth Inc. has partnered with Ace Venture of NY, LLC, aiming to establish New York’s first scaled social equity operator under the state’s initiative for minority-owned vertically integrated medical cannabis licenses.
Finally, Jimmy Kimmel is reportedly executive producing a new Hulu docuseries focused on cannabis culture.